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Introduction
In healthy adults the constant large-scale production of
mature red blood cells (RBC) is counterbalanced by the clear-
ance of aged or damaged RBC. The bone marrow (BM) is the
primary erythropoietic organ with the spleen becoming
important during acute or chronic stress. Erythroid progenitor
cells interact with BM macrophages to form multicellular
clusters termed erythroblastic islands (EBI).1,2 Within this
microenvironment, macrophages are thought to supply the
rapidly hemoglobinizing erythroblasts with iron and growth
factors. Erythroblasts condense and expel their nuclei in a
process termed enucleation.3 BM macrophages engulf and
destroy these free nuclei leading to the release of anuclear
reticulocytes into the circulation,4,5 where they rapidly mature
to RBC which then circulate for ~35-50 days in the mouse6,
and 120 days in the human.
Erythrocyte clearance typically takes place in the spleen,
where phagocytes engulf and destroy aged or damaged RBC.
Exposure of phosphatidylserine on the RBC surface is a fea-
ture of aging, and the recognition of such phosphatidylserine
by Tim4-expressing splenic macrophages leads to RBC
engulfment and destruction.7,8 A critical stage in RBC clear-
ance is the hemoglobin breakdown and catabolism of
released heme into carbon monoxide, iron and biliverdin9 by
heme oxygenase-1 (encoded by Hmox1).10 Biliverdin reductase
then converts biliverdin to the potent antioxidant bilirubin.11
Mice lacking both copies of Hmox1 exhibit a range of severe
defects. Firstly, only ~10-20% of expected Hmox1-deficient
animals are born alive suggesting that most die in utero.12
Secondly, the Hmox1-null mutant animals that reach adult-
hood show numerous health problems including altered
spleen morphology and function, vascular injury, renal and
hepatic damage, and an increased sensitivity to oxidative
stress and endotoxemia.13-15 Moreover, in Hmox1–/– mice, initial
splenic enlargement progresses to red pulp fibrosis, atrophy,
and functional hyposplenism in animals older than 9
months,16 reminiscent of the asplenia in the extremely rare
HMOX1-null patients who also present with anemia, micro-
cytosis and abnormal iron metabolism.15,17,18 Furthermore,
polymorphisms in the HMOX1 gene promoter which can
affect the extent of gene transcription are associated with a
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Heme oxygenase-1 is critical for iron recycling during red blood cell turnover, whereas its impact on steady-state
erythropoiesis and red blood cell lifespan is not known. We show here that in 8- to 14-week old mice, heme oxy-
genase-1 deficiency adversely affects steady-state erythropoiesis in the bone marrow. This is manifested by a
decrease in Ter-119+-erythroid cells, abnormal adhesion molecule expression on macrophages and erythroid cells,
and a greatly diminished ability to form erythroblastic islands. Compared with wild-type animals, red blood cell
size and hemoglobin content are decreased, while the number of circulating red blood cells is increased in heme
oxygenase-1 deficient mice, overall leading to microcytic anemia. Heme oxygenase-1 deficiency increases oxida-
tive stress in circulating red blood cells and greatly decreases the frequency of macrophages expressing the phos-
phatidylserine receptor Tim4 in bone marrow, spleen and liver. Heme oxygenase-1 deficiency increases spleen
weight and Ter119+-erythroid cells in the spleen, although α4β1-integrin expression by these cells and splenic
macrophages positive for vascular cell adhesion molecule 1 are both decreased. Red blood cell lifespan is prolonged
in heme oxygenase-1 deficient mice compared with wild-type mice. Our findings suggest that while macrophages
and relevant receptors required for red blood cell formation and removal are substantially depleted in heme oxy-
genase-1 deficient mice, the extent of anemia in these mice may be ameliorated by the prolonged lifespan of their
oxidatively stressed erythrocytes. 
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ABSTRACT
range of clinical pathologies, including idiopathic recurrent
miscarriage,19 fetal hemoglobin expression in Brazilian
patients with sickle cell anemia,20 and pre-eclampsia.21
Splenic macrophages are central to whole body iron
recycling and return the iron from cleared RBC to the BM
for use in erythropoiesis.16,22 Hmox1 plays a critical role in
this iron recycling and regulates the ability of splenic
macrophages to tolerate the toxic heme released during
RBC clearance.16 Hmox1 is expressed in splenic
macrophages and is up-regulated in other cell types in
response to heme and oxidative stress.23 Splenic
macrophages are significantly decreased in mice lacking
Hmox1,16 resulting in iron redistribution from the spleen
and hepatic Küpffer cells to hepatocytes and proximal
tubular cells of the kidney.16 Inappropriate handling of
heme and tissue deposition of iron in Hmox1–/– mice and
HMOX1-deficient patients results in increased oxidative
stress and vascular cell injury.16,17 Hematopoiesis and stress
erythropoiesis in Hmox1+/– mice has been investigated
recently. BM cells from Hmox1+/– mice are less capable of
reconstituting lethally irradiated recipient animals.24
Moreover, mice with a hematopoietic system reconstitut-
ed from Hmox1+/– donor animals demonstrate decreased
stress erythropoiesis in response to anemia.25
Here, we investigated erythropoiesis in the complete
absence of the Hmox1 gene and protein expression and
without exerting exogenous stress in young, 8- to 14-week
old mice. We found significant alterations in the BM, cir-
culating and splenic erythroid populations in Hmox1–/–
mice. In the BM, the number of EBI macrophages was
decreased and the expression of adhesion molecules was
altered in erythroblast and macrophage populations, man-
ifested as the inability of Hmox1-deficient BM to form EBI.
Hmox1-deficient RBC also showed profound changes in
redox biology and lifespan. Splenic erythropoiesis was
almost completely absent and splenic macrophages
involved in RBC removal were severely depleted. Our
findings document defects in RBC production and lifespan
resulting from the loss of this crucial heme-catabolizing
enzyme.
Methods
Full details of the materials and methods are provided in the
Online Supplementary Methods.
Mice
Hmox1+/– breeders on a BALB/c background were obtained from
Dr MP Soares (Instituto de Gulbenkian de Ciencia, Portugal) from
a colony generated originally by Dr SF Yet.26 Male and female
mice, 8 to 14 weeks old,  Hmox–/–, Hmox1+/– and Hmox1+/+ littermates
obtained from Hmox1+/– x Hmox1+/– breeding, were used for exper-
iments. All procedures were carried out according to the
Australian NHMRC guidelines for animal research and were
approved by the Animal Care and Ethics Committees of the
University of Sydney and the Garvan Institute of Medical
Research/St Vincent's Hospital.
Flow cytometry and cytological analysis
Blood, BM, spleen and liver single cell suspensions were treated
with FcR-block (MACS Miltenyi Biotech) then with appropriate
antibodies for 1 h at 4°C. A list of antibodies is presented in Online
Supplementary Table S1. The presence of a nucleus or surface mem-
brane phosphatidylserine was assessed as described in the Online
Supplementary Methods. Resuspended samples were analyzed using
FACSCalibur (Becton Dickinson) and FlowJo software. Iron stain-
ing was performed on methanol-fixed cytospun BM samples using
the Iron Stain Kit (Sigma Aldrich) according to the manufacturer’s
instructions.   
Isolation and imaging of erythoblastic islands
EBI were obtained from BM as described elsewhere,27 with
modifications described in the Online Supplementary Methods. For
confocal microscopy imaging, cells were permeabilized and fixed,
before treatment with AlexaFluor 647-conjugated phalloidin (Life
Technologies) and imaging using a Leica SPEII confocal micro-
scope. 
Scanning electron microscopy
The pelleted RBC and EBI underwent standard work-up proce-
dures required for scanning electron microscopy imaging, as
described in the Online Supplementary Methods.
Red blood cell production and lifespan
RBC production and lifespan were determined using in vivo car-
boxyfluorescein diacetate succinimidyl ester (CFSE) labeling,6 with
slight modifications described in the Online Supplementary Methods.
The number of CFSE–-RBC over time indicates RBC production,
whereas the number of CFSE+-RBC over time indicates lifespan. A
second strategy involved transfusing CSFE-labeled RBC from
Hmox1+/+ into Hmox1+/+ or Hmox1–/– mice.
Biochemical analyses
Freshly collected blood (1 vol) was added to 1 vol of 200 mM N-
ethylmaleimide in EDTA tubes and incubated at room tempera-
ture for 1 h, before the native redox state of peroxiredoxin 2 (Prx2)
was determined.28 Heparinized blood was centrifuged and cells
washed and incubated for 10 min at 37°C with hydrogen peroxide
(0–150 µM). Cells were alkylated with N-ethylmaleimide for 1 h.
Protein concentrations were determined and Prx2 redox state
assessed. Blood hemoglobin was determined by the Drabkin
method,29 while plasma hemoglobin and erythropoietin were
assessed by enzyme-linked immunosorbent assay. Heme and
bilirubin were analyzed by liquid chromatography-tandem mass
spectrometry.
Statistical analysis
Details regarding the statistical analysis are presented in the
Online Supplementary Methods.
Results
By 20 weeks of age, 129/Sv x C57BL/6 chimeras of
Hmox1–/– mice display systemic inflammation and disor-
dered iron metabolism characterized by microcytic ane-
mia, anisocytosis, decreased serum iron, splenomegaly,
and iron deposition in the liver and kidney.12,16 As genetic
background and age affect phenotypes, the current study
used comparatively young (8 to 14 weeks old) Hmox1–/–
mice back-crossed for ≥14 generations onto the BALB/c
genetic background. Compared with Hmox1+/+ littermates,
Hmox1–/– mice also showed splenomegaly and a decrease
in hematocrit and hemoglobin (Table 1), indicating that
Hmox1 deficiency causes anemia even in young adult mice
prior to the progressive inflammation present in older ani-
mals.12 Hematologic parameters of Hmox1+/– animals have
not been reported previously even though a decrease in
Hmox1 is associated with vascular and hematopoietic
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alterations. Most parameters were not altered in Hmox1+/–
mice compared with wild-type animals, except for the sig-
nificant increase in plasma hemoglobin in heterozygous
mice. This demonstrates that Hmox1 gene dosage is
important in regulating hemoglobin clearance, although
this was not investigated further. We also determined
plasma concentrations of heme and bilirubin, the substrate
for Hmox1 and end-product of heme catabolism, respec-
tively, as such information is currently lacking. We
observed that plasma hemoglobin and heme were
increased and bilirubin decreased in Hmox1–/– mice com-
pared with Hmox1+/+ and Hmox1+/– mice (Table 1).
Hmox1 deficiency alters steady-state erythropoiesis
As the BM is the primary site for erythropoiesis, we first
examined the frequency of BM erythroid cells identified
by the lineage-specific surface antigen Ter-119. The pro-
portion of nucleated and enucleated BM cells being Ter-
119+ was decreased significantly in Hmox1–/– compared
with Hmox1+/+-and Hmox1+/– mice (Figure 1A). Consistent
with the suggested impairment of steady-state erythro-
poiesis in Hmox1 deficiency, bones and BM cells collected
from Hmox1+/+ and Hmox1+/– mice generally appeared more
pigmented than their counterparts from Hmox1–/– mice
(Online Supplementary Figure S1). We next subjected Ter-
119+CD71+ BM cells to flow cytometry to quantify ery-
throid cells as they differentiate from pro-erythroblasts
(R1), into basophilic (R2), polychromatophilic (R3) and
orthochromatophilic erythroblasts (R4) (Figure 1B), as ver-
ified previously.30 Hmox1 deficiency caused a blockade of
erythroid maturation in the R1 stage, leading to a signifi-
cant decrease in R3 (Figure 1B). Similar results were
obtained when the different erythroid developmental
stages were segregated using expression of Ter-119, the
adhesion molecule CD44 and cell size31 (Figure 1C). A con-
sistent reduction in the frequency of “population V” cells
was observed. Both R3 and “population V” identify retic-
ulocytes. 
The above results show that Hmox1 regulates steady-
state erythropoiesis, and they suggest that Hmox1 defi-
ciency decreases the frequency of reticulocytes in the BM.
We therefore asked if Hmox1 deficiency causes a decrease
in the numbers of RBC formed and released into the circu-
lation. To do so, we determined the time-dependent
appearance of CFSE–-RBC in the circulation of mice after
in vivo labeling of their blood cells with CFSE.32 The num-
bers of RBC released into circulation were comparable in
Hmox1–/–, Hmox1+/– and Hmox1+/+ mice (Figure 1D).
However, Hmox1 deficiency caused a significant decrease
in the mean corpuscular diameter, volume and hemoglo-
bin content of circulating RBC (Table 1), as has been
reported previously for older animals.12 The extent of
decrease in RBC corpuscular hemoglobin was comparable
to the 20% decrease in whole blood hemoglobin, whereas
the ratio of RBC corpuscular hemoglobin to volume was
unaffected by Hmox1 deficiency (Table 1). Scanning elec-
tron microscopy and size assessment (Online
Supplementary Figure S2) confirmed these findings, indicat-
ing that the abnormal erythropoiesis observed in Hmox1
deficiency results in microcytic anemia and an associated
decrease in whole blood hemoglobin.
Hmox1 deficiency disrupts bone marrow 
macrophage-erythroblast interactions
During erythroid maturation, erythroid progenitors
interact with the central macrophages of EBI in BM. We
first determined Hmox1 expression in EBI by immuno -
staining and confocal imaging. As can be seen (Figure 2A),
Hmox1 protein is abundantly expressed by the central EBI
macrophages. We next assessed the impact of Hmox1
deficiency on EBI. EBI from wild-type mice yielded typical
‘EBI rosettes’, consisting of F4/80+ macrophages and their
companion Ter-119+ erythroblasts (Figure 2B, middle
panel). Despite repeated attempts, clusters from Hmox1–/–
BM did not remain adhered to the coverslip after the
numerous incubation and wash steps involved in the
immunolabeling procedure. Rare individual macrophages
could be observed (Figure 2B, right panel), but these were
never observed in clusters associating with erythroblasts.
To examine the impact of Hmox1 on EBI formation fur-
ther, EBI were immediately fixed and processed for scan-
ning electron microscopy. These experiments showed that
wild-type BM macrophages readily adhered to and spread
across the surface of the coverslip with adhering erythroid
progenitors and, occasionally, reticulocytes (Figure 2C).
The morphology of most Hmox1+/– EBI was similar to that
of wild-type EBI, although some appeared disrupted and
their macrophages ruffled. Compared with wild-type EBI,
the few EBI that could be obtained from Hmox1–/– mice
were smaller, contained fewer erythroblasts and showed
profound abnormalities in structure and morphology:
macrophages appeared dome-shaped (rather than flat-
tened) and stressed, with a ruffled and abnormal cell
membrane (Figure 2C, bottom right).
To identify the causes of EBI failure in Hmox1–/– mice, we
Table 1. Characteristics of mice with Hmox1 deficiency.
Parameter Hmox1+/+ Hmox1+/– Hmox1–/–
Spleen weight (mg) 112 ± 4 113 ± 7 479 ± 27*
(n=11) (n=5) (n=8)
Hematocrit (%) 47.0 ± 0.7 47.0 ± 1.7 39.3 ± 1.6*
(n=15) (n=6) (n=11)
Whole blood hemoglobin (g/dL) 16.1 ± 0.3 16.4 ± 0.3 12.9 ± 0.2*
(n=11) (n=8) (n=6)
RBC numbers (x 1012/L) 11.4 ± 0.3 11.9 ± 1.0 13.6 ± 1.5*
(n=6) (n=3) (n=4)
Red blood cell diameter (µm) 6.3 ± 0.1 6.3 ± 0.1 5.6 ± 0.1*
(n=10) (n=6) (n=9)
Mean corpuscular volume, (fL) 39 ± 1 41.9 ± 1.8 32.4 ± 1.7*
(n=8) (n=6) (n=8)
Mean corpuscular hemoglobin, (pg) 16.2 ± 1 13.6 ± 1 11.2 ± 0.9*
(n=8) (n=6) (n=8)
MCH/MCV (pg/fL) 0.42 ± 0.03 0.33 ± 0.04 0.36 ± 0.04
(n=8) (n=6) (n=8)
Plasma erythropoietin (pg/mL) 103 ± 8 100 ± 7 148 ± 14*
(n=4) (n=5) (n=5)
Plasma hemoglobin (µg/mL) 78 ± 3 227 ± 8* 579 ± 258*
(n = 3) (n = 4) (n = 6)
Plasma heme (µmol/L) 0.5 ± 0.04 0.9 ± 0.3 2.2 ± 0.5*
(n=3) (n=3) (n=5)
Plasma bilirubin (µmol/L) 1.9 ± 0.6 2.2 ± 0.3 0.7 ± 0.1*
(n=3) (n=3) (n=5)
Individual parameters were determined as described in the Online Supplementary Methods.
Results shown represent mean ± SEM. *P<0.05 compared with Hmox1+/+. RBC: red blood cell;
MCH: mean corpuscular hemoglobin; MCV: mean corpuscular volume.
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examined the expression of α4β1-integrin on BM Ter-
119+-erythroid cells, as erythroid cells express Hmox1,33
α4-integrin regulates terminal erythroid maturation,34 and
α4β1-integrin interaction with macrophage vascular cell
adhesion molecule 1 (VCAM-1) is a key determinant of
EBI formation.1,35 Ter-119+-cells of Hmox1–/– mice expressed
higher levels of α4β1-integrin than the corresponding cells
from Hmox1+/+ and Hmox1+/– animals (Figure 3A), indicating
that limited erythroid integrin expression was not respon-
sible for the observed failure of BM from Hmox1–/– mice to
form EBI. 
We next employed a recently described detailed charac-
terization of EBI macrophages, using a cocktail of differ-
ently labeled antibodies directed against six antigens.36 BM
from Hmox1–/– mice had significantly decreased numbers
of EBI macrophages expressing the surface antigens F4/80,
VCAM 1, CD11b, Ly6G, CD169 and ER-HR3 (Figure 3B).
Consistent with this observation, the expression of the
glycosphingolipid Forssman antigen, a specific marker for
EBI-macrophages,37 was decreased profoundly in BM
macrophages of Hmox1–/– compared with Hmox1+/+ and
Hmox1+/– mice (Figure 3C). These results indicate that BM
of Hmox1–/– animals have a limited ability to form EBI
because the numbers of EBI macrophages are decreased.
Iron staining of BM cells revealed a build-up of redox-
active iron in macrophages or Hmox1–/– compared with
Hmox1+/+ mice (Online Supplementary Figure S3).
Interestingly, despite the defects in iron metabolism in
Hmox1–/– mice, no ring sideroblasts were observed.
Hmox1 deficiency alters circulating and splenic 
erythroid population frequency
Plasma erythropoietin was significantly increased in
Hmox1–/– compared with Hmox1+/– and Hmox1+/+ mice
(Table 1). Correspondingly, we observed an increase in cir-
culating nucleated erythroid (Figure 4A) and α4-
integrin+Ter-119+ cells (Figure 4B). The latter include both
erythroblasts and reticulocytes. Compared with Hmox1+/+,
circulating Ter-119+CD71+-cells were increased in Hmox1–/–
mice (Figure 4C), suggesting that erythroblastosis takes
place in these animals.
We next examined whether the observed erythroblasto-
sis was associated with increased erythropoiesis in the
spleen. The proportion of splenic Ter-119+-cells was
increased significantly in Hmox1–/– mice (Figure 4D). This
increase, combined with the decrease in Ter-119+ cells in
the BM (Figure 1A), suggest that the erythropoiesis defect
seen in Hmox1–/– mice is specific for BM. However, the
spleen of Hmox1–/– mice also exhibited decreased
basophilic (R2) and polychromatophilic (R3) erythroblast
S.T. Fraser et al.
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Figure 1. Altered steady-
state erythropoiesis in the
BM of Hmox1–/– mice.
Erythroid maturation in BM
of Hmox1+/+ (n=6), Hmox1+/–
(n=3) and Hmox1–/– mice
(n=5) was assessed by flow
cytometry. (A) Proportion of
nucleated and enucleated
Ter-119+ BM cells. (B)
Representative flow cytomet-
ric profiles and quantification
of maturing erythroid popula-
tions R1-R4 as assessed by
Ter-119 and CD71 surface
expression. Results show the
different populations as a
percent of total cells. (C)
Representative flow cytomet-
ric profiles and quantification
of stages of erythroid differ-
entiation as assessed by Ter-
119 and CD44 expression in
combination with forward
scatter.31 (D) Graphic repre-
sentation of the number of
CFSEnegative-RBC over 48 days
in Hmox1+/+ (circles),
Hmox1+/– (diamonds) and
Hmox1–/– mice (squares)
(n=3 each). *P<0.05 com-
pared with Hmox1+/+ and
Hmox1+/–.
A
B
C
D
frequency, while the most mature erythroid cells (R4)
were increased (Figure 4E), suggesting that stress erythro-
poiesis was also affected by Hmox1 deficiency. To assess
this further, we examined spleen Ter-119+-cells for their
expression of α4-integrin as well as α5-integrin. The latter
regulates the interaction of stress erythroblasts with the
splenic microenvironment.38 The expression of both α4-
(Figure 4F) and α5-integrin (data not shown) in splenic ery-
throid cells of Hmox1–/– mice was decreased substantially
compared with the expression in Hmox1+/+ or Hmox1+/– ani-
mals. This suggests that stress erythropoiesis, character-
ized by the influence of large numbers of integrin-express-
ing R2 and R3 erythroblasts, is not a major player in the
maintenance of relatively normal RBC levels in Hmox1–/–
mice.
Hmox1 deficiency increases red blood cell lifespan
We next examined the impact of Hmox1 deficiency on
parameters known to regulate the removal of circulating
RBC. For this, RBC were assessed first for signs of
increased oxidative stress, using oxidized Prx2 as a marker.
Prx2 is a thiol-dependent peroxidase essential for sustain-
ing the lifespan of RBC in mice,39 and the third most abun-
dant RBC protein.40 Upon reaction with hydrogen perox-
ide (H2O2), the Prx2 monomer is oxidized to two forms of
dimers that contain one or two disulfide bonds and that
can be separated and detected by western blotting.41 An
increase in the ratio of Prx2 dimers to monomers reflects
increased oxidative stress.40,41 When treated in vitro with
reagent H2O2, Prx2 dimers formed at lower oxidant con-
centrations in isolated RBC from Hmox1–/– compared with
Hmox1+/+ mice (Figure 5A), consistent with a previous
study14 showing that RBC from Hmox1–/– mice were hyper-
sensitive to oxidants ex vivo. In addition, freshly isolated
RBC from Hmox1–/– mice contained a higher proportion of
Prx2 as dimers compared with cells from Hmox1+/+ mice
even in the absence of an added oxidant (Figure 5B). This
shows for the first time that Hmox1 deficiency increases
endogenous oxidative stress in circulating RBC, possibly
as a consequence of the elevated plasma concentrations of
the pro-oxidant heme (Table 1).
The rate of removal of circulating RBC was then meas-
ured by in vivo labeling of cells with CFSE.32 Compared
with RBC in Hmox1+/– and Hmox1+/+ mice, RBC in Hmox1–/–
mice were removed at a significantly slower rate, as deter-
mined by the percentage of CFSE+-RBC remaining over
Heme oxygenase-1 deficiency and erythropoiesis
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Figure 2. EBI formation is defective in
Hmox1–/– mice. (A) Hmox1 is expressed by
EBI central macrophages. EBI were obtained
as described in the Methods, fixed and
stained with isotype control antibody (left
panel) or antibodies against Hmox1 (yellow)
and F4/80 (red). Cells were counterstained
with DAPI to indicate the nuclei (blue).
Hmox1 is abundantly expressed by F4/80+
EBI central macrophages (right panel). (B)
Macrophages from BM of Hmox1–/– mice
cannot be identified in multicellular clusters.
EBI assays were performed as described in
the Methods from wild-type and Hmox1-defi-
cient bone marrow, fixed and immunos-
tained with Ter-119 (green) and F4/80 (red)
antibodies. Multicellular EBI could be identi-
fied readily in wild-type samples (middle
panel) whereas in samples from Hmox1–/–
mice BM adherent macrophages could be
detected as individual cells. (C) EBI morphol-
ogy revealed by scanning electron
microscopy. EBI, obtained from BM of
Hmox1+/+, Hmox1+/– and Hmox1–/– mice as
described in the Methods, were assessed by
scanning electron microscopy. Five EBI are
shown for each genotype. Bottom panels
show pseudo-colored images with
macrophages in blue and hematopoietic
progenitor cells in red. Hmox1+/+ EBI (left
panel) attached to and spread across the
surface of the glass coverslip with smaller
erythroblasts clearly adherent. Hmox1+/– EBI
(middle panel) showed different morpholo-
gy, ranging from those resembling wild-type
EBI (top left, middle and bottom panels) to
EBI showing abnormal macrophages (top
right). Hmox1–/– EBI (right panel) were repeat-
edly observed with abnormal morphology.
Hmox1–/– macrophages failed to extend,
spread out and tether hematopoietic progen-
itor cells. Hmox1–/– macrophages failed to
spread across the coverslip and in some
cases showed signs of stress with ruffled cell
membranes and erratic cytoplasmic projec-
tions (bottom pseudo-colored panel).
A
B
C
time (Figure 5C). The estimated average lifespan for RBC
in Hmox1–/– mice was longer (48.8±0.1 days) than that for
Hmox1+/+ and Hmox1+/– mice (i.e., 44.1±0.8 and 44.0±2.5
days, respectively; mean ± SEM, n=3 for each of the three
genotypes). These results suggest that the removal of
senescent RBC was compromised in Hmox1–/– mice. We
therefore performed transfer lifespan studies with CFSE-
labeled RBC. We observed that RBC from Hmox1+/+ mice
were removed significantly slower in Hmox1–/– recipients
than in Hmox1+/+ recipients (Figure 5D), consistent with the
notion that RBC lifespan is increased in Hmox1–/– mice as a
result of extrinsic factors, i.e., compromised RBC removal,
rather than RBC intrinsic factors. Consistent with this,
splenic F4/80+-macrophages expressing CD11b (Figure 5E)
and VCAM-1 (Figure 5F) were severely depleted in Hmox1–
/– mice, and we found no differences in the phos-
phatidylserine content or osmotic fragility of blood RBC
from Hmox1+/+ and Hmox1–/– mice (data not shown).
The liver can serve as an extramedullary hematopoietic
organ and also clear aged RBC under stress conditions.
However, CD71+Ter-119+ erythroblasts occurred with
comparable frequency in dispersed liver cells of Hmox1+/+,
Hmox1+/– and Hmox1–/– mice (Figure 6A). Hepatic F4/80+
cells were decreased in Hmox1–/– mice (data not shown),
although not as drastically as observed in the spleen of
these animals. Similarly, macrophages lacking VCAM-1
and the phosphatidylserine receptor Tim4 were more
abundant in the liver of Hmox1–/– than Hmox1+/+ and
Hmox1+/– mice (Figure 6B), with this decrease in Tim4-
expressing F4/80+ cells being less severe in the liver than in
BM and spleen (Figure 6C). These results indicate that the
liver in animals lacking Hmox1 does not engage consis-
tently in erythropoiesis, and that the population of hepatic
macrophages responsible for RBC clearance is decreased
in Hmox1 deficiency.
Discussion
The beginning and end of an erythrocyte’s life are book-
ended by interactions with macrophages: BM
macrophages are considered essential supportive elements
in RBC formation and maturation,42,43 and splenic
macrophages remove aged or damaged RBC. Hmox1
plays a critical role in the recycling of whole body iron by
releasing iron from heme derived from RBC being
removed by splenic macrophages; such iron is then made
available for the next wave of emerging erythroid cells.16
Free heme is a strong oxidant and cytotoxic,44 and the
inability of Hmox1-deficient splenic macrophages to toler-
S.T. Fraser et al.
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Figure 3. Hmox1 deficiency
reduces the frequency of
EBI island macrophages. (A)
Representative flow cyto-
metric profiles (top) and
quantification (bottom) of
α4β1 integrin expression on
Ter-119+-cells from BM of
Hmox1+/+ (n = 8), Hmox1+/–
(n = 4) and Hmox1–/– mice (n
= 6). (B) Representative flow
cytometric profiles (top) and
quantification (bottom) of
macrophages expressing
F4/80+ VCAM 1+ CD11b+
Ly6G+ CD169+ ER-HR3+,
showing decreased EBI
macrophages in the BM of
Hmox1–/– (n=3) compared to
Hmox1+/+ (n=3) and
Hmox1+/– (n=3) mice. (C)
Representative flow cyto-
metric profiles (top) and
quantification (bottom) indi-
cate that BM F4/80+-
macrophages of Hmox1–/–
mice (n = 8) have decreased
expression of the Forssman
antigen, specific for EBI cen-
tral macrophages, com-
pared with Hmox1+/+ (n =
10) and Hmox1+/– (n = 5)
mice *P<0.05 compared
with Hmox1+/+ and Hmox1+/–
.
A B
C
ate heme leads to their death and disruption of the iron
recycling process.12 Here, we show that Hmox1 also plays
significant roles in regulating erythroid cell-macrophage
interactions in the BM.
BM from mice lacking Hmox1 is severely depleted of
EBI macrophages. This is associated with a decrease in the
expression of VCAM-1 (Figure 3B, top panels), necessary
for interactions with α4β1 integrin on neighboring ery-
throblasts. During erythroid cell maturation, the nucleus
becomes condensed and expelled, surrounded by a thin
layer of hemoglobin-containing cytoplasm45 and encapsu-
lated in an erythroid cell membrane replete with α4β1
integrin.46 We propose that these hemoglobin-containing,
expelled nuclei are engulfed preferentially by VCAM-1+-
macrophages, leading to Hmox1 induction seen in wild-
type EBI macrophages (Figure 2A). We further propose
that an inability to catabolize the heme present in ‘pyreno-
cytes’47 leads to the selective death of VCAM-1+-
macrophages in Hmox1 deficiency. Such proposed selec-
tive loss of VCAM-1+-macrophages, rather than a decrease
in VCAM-1 expression by BM macrophages, is also sup-
ported by the observation that Hmox1 deficiency increas-
es47 and Hmox1 induction decreases VCAM-1 expres-
sion.47-49 These changes in erythroblast-macrophage inter-
actions are exemplified best by the scanning electron
microscopy analysis of EBI (Figure 2C). High-resolution
images of EBI illustrate the morphology of the central
island macrophage and erythroblasts attached to it. In BM
from Hmox1–/– mice, we observed highly abnormal EBI
macrophages with domed morphology rather than flat-
tened, spread-out morphology. These EBI also lacked clear
interactions with erythroblasts. Thus, normal EBI forma-
tion no longer appears possible in Hmox1 deficiency. This
deficiency likely contributes to alterations in erythro-
poiesis including microcytosis, abnormal cell membranes,
reticulocytosis and erythroblastosis.
Few individuals are born with complete HMOX1 defi-
ciency. These rare patients exhibit numerous similarities
to the mouse null mutant. Notably, erythropoiesis does
occur although it is abnormal. HMOX1-deficient patients
also show altered monocyte phenotype and functions
including phagocytosis.15 BM macrophage phenotype and
functions have not been assessed in HMOX1-deficient
patients. The erythroid defects observed in HMOX1-defi-
cient patients could, therefore, also arise from defective
erythroid cell-macrophage interactions in the BM, as we
have observed in the null mutant mouse model.
Furthermore, decreased expression of HMOX1 due to
polymorphisms in the HMOX1 gene promoter is associat-
ed with a number of pathological conditions including dif-
ficulties in pregnancy. It is feasible that the differences
observed in the Hmox1+/– animals (increased plasma hemo-
globin for example) are involved in the pathologies
observed in patients with HMOX1 polymorphisms.
Our studies provide direct evidence that Hmox1 defi-
ciency increases RBC lifespan, likely by attenuating
macrophage-mediated RBC removal in the spleen, liver
and BM by decreasing both macrophage numbers and
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Figure 4. Absence of Hmox1
alters circulating and splenic
erythroid population frequency.
Hmox1 deficiency increases
circulating erythroid cells that
stain with (A) DRAQ5, (B) the
erythroblast marker α4-inte-
grin, and (C) CD71 (n = 5, 3 and
6 for Hmox1–/–, Hmox1+/– and
Hmox1+/+ mice, respectively).
(D) Increased frequency in Ter-
119+ erythroid cells in the
spleen of Hmox1–/– (n = 5) com-
pared with Hmox1+/+ (n = 6)
and Hmox1+/– (n = 3) mice. (E)
Splenic erythroid maturation in
Hmox1+/+ (black, n = 6),
Hmox1+/– (gray, n = 3) and
Hmox1–/– mice (white, n = 5) as
assessed by expression of Ter-
119+ and CD71+. (F) Decreased
frequency of Ter-119+-erythroid
cells expressing α4β1-integrin
(left panel), α4β1high (black) or
α4β1med integrin (white) (right
panel). Data show representa-
tive flow cytometric profiles
and their quantification (n = 3-
10 for different groups).
*P<0.05 compared with
Hmox1+/+ and Hmox1+/– mice.
A B C
D
F
E
Tim4 expression. This may be explained in ways analo-
gous to the specific depletion of BM VCAM-1+-
macrophages (see above). Whether the elevated oxidative
stress experienced by RBC from Hmox1–/– mice and indi-
cated by their increased content of oxidized Prx228 affects
lifespan remains to be investigated, e.g., by transfer exper-
iments of labeled RBC from Hmox1–/– mice into Hmox1+/+
and Hmox1–/– mice. The corresponding decrease in non-
oxidized Prx2 could conceivably attenuate RBC lifespan
and increase compensatory erythropoietin synthesis,39 as
seen in Hmox1–/– mice. Because Hmox1 is not present in
RBC, we interpret their increased content of oxidized Prx2
in Hmox1 deficiency as the result of an increased exposure
to oxidants rather than a decrease in antioxidant defens-
es.13 This interpretation is consistent with our observation
that Hmox1 deficiency is associated with elevated plasma
concentrations of the pro-oxidant heme (Table 1).
The present study does not reveal precisely how RBC
are removed in Hmox1 deficiency. Previous studies have
reported the accumulation of iron in hepatocytes and kid-
neys of Hmox1–/– mice,12,16 suggesting that cells in these tis-
sues may compensate for decreased RBC clearance by
splenic macrophages and the associated reduced heme
degradation. What is clear from these previous studies,12,16
however, is that such (or any other) compensatory heme
catabolism operative in Hmox1 deficiency is less efficient
in iron recycling compared with Hmox1-mediated heme
degradation, as Hmox1–/– mice are anemic. Our studies
argue against a fully compensatory role for the constitu-
tively expressed heme oxygenase-2 in heme degradation
in Hmox1–/– mice. This is because the decrease in circulat-
ing bilirubin exceeded that of hematocrit and whole blood
hemoglobin in Hmox1–/– mice by ~3-fold, compared with
Hmox1+/+ mice (Table 1). Thus, the precise site and mecha-
nism of heme degradation in Hmox1–/– mice remain to be
established.
The current study raises the intriguing question of how
near normal erythropoiesis is maintained in Hmox1 defi-
S.T. Fraser et al.
608 haematologica | 2015; 100(5)
Figure 5. Hmox1 deficiency increas-
es systemic oxidative stress and
RBC lifespan. (A) Greater suscepti-
bility of RBC from Hmox1–/– (n = 6)
than Hmox1+/+ animals (n = 7) to oxi-
dation induced by added H2O2.
Representative western blots (left)
showing oxidation of Prx2
monomer to Prx2 dimers with
increasing concentrations of H2O2,
with the upper and lower dimer
band representing Prx2 with one
and two disulfide bonds, respective-
ly.41 Graphic representation of the
densitometry data on the right. (B)
Increased systemic endogenous
oxidative stress in Hmox1 deficien-
cy indicated by an increase in the
percentage of endogenous RBC
Prx2 present as dimers in Hmox1–/–
(n = 6) compared with wild-type
mice (n = 7). (C) Increase in the lifes-
pan of RBC in Hmox1–/– (squares)
compared with Hmox1+/+ (circles)
and Hmox1+/– mice (diamonds)
(n=3 each), as determined by the
percentage of CFSE+-RBC detected
over a 48-day period following in
vivo CFSE labeling. *P<0.05 com-
pared with Hmox1+/+ and Hmox1+/–
as assessed by two-way ANOVA. (D)
Increased lifespan of in vivo CFSE-
labeled RBC from wild-type (WT)
after transfer to Hmox1–/– com-
pared with Hmox1+/+ mice, deter-
mined (n = 3 per treatment).
*P<0.05 compared with Hmox1+/+
and Hmox1+/– as assessed by two-
way ANOVA. (E, F) Decreased fre-
quency of F4/80+-macrophages
expressing CD11b and VCAM-1 in
Hmox1–/– compared with Hmox1+/+
and Hmox1+/– mice (n=3 each).
*P<0.05 compared with Hmox1+/+
and Hmox1+/–.
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ciency despite the almost complete absence of BM EBI.
Interestingly, efficient enucleation has been reported to take
place in the absence of macrophages during the in vitro dif-
ferentiation of hematopoietic stem and progenitor cells.50
Macrophages may not, therefore, be absolutely essential for
in vivo erythropoiesis, although small numbers of VCAM-1+
and Forssman ligand+ macrophages remain present in the
BM of Hmox1–/– mice. Some erythropoiesis takes place in
the spleen, as demonstrated by the presence of erythro -
blasts in Hmox1+/+ and Hmox1–/– mice. Indeed, spleen size
and proportion of splenic erythroid cells are increased in
Hmox1–/– compared with control mice, possibly compensat-
ing for the defect in BM erythropoiesis. However, in the
Hmox1–/– spleen erythroblasts are decreased profoundly rel-
ative to other erythroid cells and the majority of erythroid
cells do not express α4β1 integrin, suggesting that stress
erythropoiesis is not the major form of compensatory RBC
production in these animals. Moreover, splenic erythro-
poiesis deteriorates as Hmox1–/– mice age and their spleens
become increasingly fibrotic. Clearly, additional investiga-
tions aimed at answering some of the questions our study
raises are warranted, as they will provide novel insights into
basic mechanisms governing the formation and removal of
RBC. As well as advancing our knowledge, such studies
may provide novel treatment options for the rare cases of
HMOX1 deficiency and the anemia of diseases such as
chronic inflammatory diseases characterized by abnormal
heme turnover and iron recycling.
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Figure 6. Hepatic macrophages are
less severely affected by Hmox1 defi-
ciency than bone marrow and splenic
macrophages. (A) Erythropoiesis in
the liver of Hmox1–/– (n = 3) and
Hmox1+/+ mice (n = 3), as assessed by
the frequency of CD71+Ter-119+ ery-
throblasts. (B) VCAM-1 and Tim4
expression on hepatic macrophages
in Hmox1+/+, Hmox1+/– and Hmox1–/–
mice. Representative cytometric data
are shown from three separate exper-
iments. (C) Graphic representation of
flow cytometric data of BM, spleen
and liver cells of Hmox1+/+ (n = 10),
Hmox1+/– (n = 5) and Hmox1–/– mice
(n = 8) gated for F4/80 and exam-
ined for Tim4 expression. *P<0.05
relative to Hmox1+/+(BM and spleen)
or compared with Hmox1+/+ plus
Hmox1+/– (liver).
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